Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2026British Journal of Biomedical ScienceOpen Access

Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMuhammad Talal AminLCLouis CoussementTMTim De Meyer

Discussion

Loading...

Member takes

Overview

Review highlights challenges and innovations in assessing imprinting dysregulation in cancer, suggesting implications for clinical applications.

Key Points

  • The review aims to summarize the complexities in evaluating genomic imprinting and propose methods to advance cancer research.
  • Introduces the concepts of genomic imprinting and its relevance in cancer.
  • Summarizes common techniques to assess imprinting and associated technical challenges.
  • Discusses innovative methods integrating single-cell and single-molecule techniques to improve imprinting characterization.
  • Imprinting anomalies in cancer linked to tumor growth and complex assessment requires rigorous methods.
  • Unique technical challenges reduce clarity in interpreting imprinting patterns across heterogeneous tumor samples.
  • Future methods promise to enhance understanding and diagnosis of imprinting dysregulation in clinical settings.

Cite This Study

Amin et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf2a9faef96ed7f05572ehttps://doi.org/10.3389/bjbs.2026.16709
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.1992 · 3,307 citations
  2. 2Ube3a unsilencer for the potential treatment of Angelman syndrome2024 · 34 citations
  3. 3Multi-omics integration strategies for animal epigenetic studies — A review2021 · 54 citations
  4. 4Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation2010 · 127 citations
  5. 5A comprehensive overview of genomic imprinting in breast and its deregulation in cancer2018 · 88 citations